26 reports

The molecules developed by companies in Phase II, Preclinical and Discovery stages are ##, ## and ## respectively.

  • Lymphoma
  • Therapy
  • United States
  • Product Initiative
  • Karyopharm Therapeutics Inc.

The observed overall response rate was ##% (##% CI: ##%-##%) in patients who had progressed on prior anti-PD-## or PD-(L)## therapy and ##% (##% CI: ##%-##%) in patients naïve to PD-## or PD-(L)## therapy.

  • Lymphoma
  • United States
  • World
  • Product Initiative
  • Syndax Pharmaceuticals, Inc.

Five of the seven responding PTCL patients remain on study drug, including one at ##+ months and one at ##+ months.

  • Lymphoma
  • Pharmaceutical
  • United States
  • Company
  • Portola Pharmaceuticals, Inc.

Completed Series A ##-Dec-2013 ##-Jan-2014 ## Product Description Alaska Permanent Fund Corp (APFC) is a state-owned company that manages the assets of Alaska Permanent Fund and Alaska Mental Health Trust Fund.

  • Lymphoma
  • Therapy
  • United States
  • Company Operations
  • Juno Therapeutics Inc.

THE OBSERVED OVERALL RESPONSE RATE WAS ##% (##% CI: ##%-##%) IN PATIENTS WHO HAD PROGRESSED ON PRIOR ANTI-PD-## OR PD-(L)## THERAPY AND ##% (##% CI: ##%-##%) IN PATIENTS NAÏVE TO PD-## OR PD-(L)## THERAPY.

  • Breast Cancer
  • Lymphoma
  • United States
  • Product Initiative
  • Syndax Pharmaceuticals, Inc.

Interest on the notes is payable semi-annually on February ## and August ##, commencing August ##, 2015.

  • HIV AIDS
  • Lymphoma
  • Pharmaceutical
  • United States
  • Gilead Sciences, Inc.

SR One Ltd.

  • Lymphoma
  • Pharmaceutical
  • Therapy
  • United States
  • Celgene Corporation

The molecules developed by Companies in Pre-Registration, Filing rejected/ Withdrawn, Phase III, Phase II and Preclinical stages are ##, ##, ##, ## and ## respectively.

  • Lymphoma
  • Pharmaceutical
  • Therapy
  • United States
  • Product Initiative

ORTHO DERMATOLOGICS ANNOUNCED THE RESULTS FROM AN ANALYSIS OF THE PHASE III CLINICAL TRIAL AMAGINE- ##, WHICH EVALUATED MENTAL HEALTH COMORBIDITIES ASSOCIATED WITH PSORIASIS, SUCH AS ANXIETY AND DEPRESSION.

  • Autoimmune Disease
  • Lymphoma
  • Monoclonal Antibody
  • United States
  • Product Initiative

## ## ## ## ## PC ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## P III ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## P II ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## Tot

  • Healthcare
  • Lymphoma
  • Medical Biotechnology
  • United States
  • Product Initiative

THE PROMINENT FEATURES OF THIS REPORT ARE - ##.

  • Clinical Trial
  • Infectious Disease
  • Lymphoma
  • Therapy
  • GlaxoSmithKline plc

The study also assessed HRQoL using the SF-##, a measure commonly used to capture changes in quality of life across various domains of physical and mental health.

  • Lymphoma
  • Monoclonal Antibody
  • Musculoskeletal Disorder
  • United States
  • Product Initiative

It offers home health and long term care services, joint replacement services, liver disease services, mental health services, and neurosciences services among others.

  • Diabetes
  • Lymphoma
  • Pharmaceutical
  • Therapy
  • Bristol-Myers Squibb Company

The study also assessed HRQoL using the SF-##, a measure commonly used to capture changes in quality of life across various domains of physical and mental health.

  • Healthcare
  • Lymphoma
  • Medical Biotechnology
  • United States
  • Product Initiative

The study also assessed HRQoL using the SF-##, a measure commonly used to capture changes in quality of life across various domains of physical and mental health.

  • Cell Therapy
  • Lymphoma
  • Specialty Hospital
  • Transplantation
  • Pluristem Therapeutics Inc.

The study also assessed HRQoL using the SF-##, a measure commonly used to capture changes in quality of life across various domains of physical and mental health.

  • Chronic Disease
  • Lymphoma
  • United States
  • Company
  • Product Initiative

It provides mental health and pediatric services.

  • Cancer
  • Lymphoma
  • United States
  • Company
  • BrainStorm Cell Therapeutics Inc.

UCB is engaged in one Phase II.

  • Immunotherapy
  • Lymphoma
  • Monoclonal Antibody
  • Therapy
  • Immunomedics, Inc.

It offers home health and long term care services, joint replacement services, liver disease services, mental health services, and neurosciences services among others.

  • Diabetes
  • Lymphoma
  • Pharmaceutical
  • Therapy
  • Bristol-Myers Squibb Company

Mental Health scores approached normal values by week ## and were maintained thereafter.

  • Cancer
  • Lymphoma
  • United States
  • Company
  • Product Initiative

THE STUDY ALSO ASSESSED HRQOL USING THE SF-##, A MEASURE COMMONLY USED TO CAPTURE CHANGES IN QUALITY OF LIFE ACROSS VARIOUS DOMAINS OF PHYSICAL AND MENTAL HEALTH.

  • Lymphoma
  • Musculoskeletal Disorder
  • United States
  • Company
  • Product Initiative

Mental Health scores approached normal values by week ## and were maintained thereafter.

  • Cancer
  • Lymphoma
  • United States
  • Company
  • Product Initiative

Mental Health scores approached normal values by week ## and were maintained thereafter.

  • Cancer
  • Lymphoma
  • United States
  • Company
  • Product Initiative

MENTAL HEALTH SCORES APPROACHED NORMAL VALUES BY WEEK ## AND WERE MAINTAINED THEREAFTER.

  • Lymphoma
  • United States
  • Company
  • Product Initiative
  • Merck & Co., Inc.

Hoffmann-La Roche Ltd. - Pipeline by Route of Administration, 2016 Intravenous ## ## ## ## ## ## ## Oral ## ## ## ## ## ## ## Subcutaneous ## ## ## ## ## ## ## Intravitreal ## ## ## ## ## ## ## Subconjunctival ## ## ## ## ## ## ## Topical ## ## ##

  • Cancer
  • Lymphoma
  • Monoclonal Antibody
  • Therapy
  • United States

Retrophin has reached an agreement with University of California (UCSD) and National Institute of Mental Health (NIMH) to serve as a collaborator of a Phase II clinical trial to measure the antipsychotic effects of intranasal oxytocin in patients with schizophrenia.

  • Cancer
  • Lymphoma
  • Targeted Therapy
  • Therapy
  • Novartis AG